Erhe Xu
Overview
Explore the profile of Erhe Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xue X, Mei S, Huang A, Wu Z, Zeng J, Song H, et al.
Brain Sci
. 2024 Aug;
14(8).
PMID: 39199480
Background: Cognitive impairment is common in patients with Parkinson's disease (PD) and occurs through multiple mechanisms, including Alzheimer's disease (AD) pathology and the involvement of α-synucleinopathies. We aimed to investigate...
2.
Cen S, Ma J, Sun H, Zhang H, Li Y, Mao W, et al.
Mov Disord Clin Pract
. 2024 Aug;
11(10):1241-1248.
PMID: 39092547
Background: Vibrotactile stimulation has been studied in its efficacy of reducing freezing of gait (FOG) in patients with Parkinson's disease (PD). However, the results are still controversial. We evaluated the...
3.
Guo W, Zhang D, Sun J, Chen L, Wu T, Xu E
Quant Imaging Med Surg
. 2024 Jul;
14(7):4464-4474.
PMID: 39022221
Background: Parkinson disease (PD) and multiple system atrophy (MSA) are neurodegenerative disorders characterized by the accumulation of alpha-synuclein. Distinguishing between these conditions remains a significant challenge. This study thus employed...
4.
Zhang Q, Xu E, Li H, Chan P, Zhao Z, Ma J
Front Neurol
. 2024 Jan;
14:1303434.
PMID: 38259657
Background: Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. Myasthenia gravis (MG) is a rare autoimmune disease caused by antibodies against the neuromuscular junction. PD...
5.
Zeng J, Song H, Liu P, Xue X, Mei S, Xu B, et al.
J Neurol Sci
. 2023 Dec;
456:122811.
PMID: 38070315
Background: Levodopa, a common drug that improves symptoms of Parkinson's disease (PD), can induce a reduction in blood pressure (BP); however, the effect of levodopa on cerebral blood flow (CBF)...
6.
Chen L, Sun J, Gao L, Wang J, Ma J, Xu E, et al.
Neurobiol Dis
. 2023 Oct;
188:106335.
PMID: 37890560
Background: Recent animal model studies have suggested that the parafascicular nucleus has the potential to be an effective deep brain stimulation target for Parkinson's disease. However, our knowledge on the...
7.
Xue X, Huang A, Zeng J, Song H, Xing Y, Chan P, et al.
Front Neurol
. 2023 Aug;
14:1149577.
PMID: 37533464
Introduction: Orthostatic hypotension (OH) frequently accompanies autonomic dysfunction and is an important risk factor for cognitive impairment in Parkinson's disease (PD). However, the association between different cognitive functions and OH...
8.
Su D, Zhang X, Su Y, Chan P, Xu E
Heliyon
. 2023 Jul;
9(7):e17876.
PMID: 37483692
Objective: Levodopa is the first-line treatment for patients with Parkinson's disease (PD). However, only a few studies have focused on the tolerance of this drug in older patients with PD...
9.
Novel mutations and molecular pathways identified in patients with brain iron accumulation disorders
Si L, Wang Z, Li X, Song Y, Yao T, Xu E, et al.
Neurogenetics
. 2023 Jul;
24(4):231-241.
PMID: 37453004
Brain iron accumulation disorders (BIADs) are a group of diseases characterized by iron overload in deep gray matter nuclei, which is a common feature of neurodegenerative diseases. Although genetic factors...
10.
Zeng J, Xing Y, Mei S, Xu B, Xue X, Song H, et al.
Front Neurol
. 2023 Feb;
14:1070943.
PMID: 36779052
Background: Multiple system atrophy (MSA) and Parkinson's disease (PD) have similar clinical presentations in their early stages. Orthostatic hypotension (OH) is a common autonomic dysfunction associated with MSA and PD....